Market Cap : 1.56 B | Enterprise Value : 1.43 B | P/E (TTM) : | P/B : 10.41 |
---|
NAS:KROS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:KROS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today, Keros Therapeutics's share price is $66.700000. Keros Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2020 was $0.14. Hence, Keros Therapeutics's P/S Ratio for today is 486.86.
Good Sign:
Keros Therapeutics Inc stock PS Ratio (=68.52) is close to 1-year low of 64.69
During the past 2 years, Keros Therapeutics's highest P/S Ratio was 590.95. The lowest was 64.69. And the median was 331.42.
Keros Therapeutics's Revenue per Sharefor the three months ended in Sep. 2020 was $0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2020 was $0.14.
During the past 12 months, the average Revenue per Share Growth Rate of Keros Therapeutics was -83.70% per year.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
* The bar in red indicates where Keros Therapeutics's PS Ratio falls into.
The P/S Ratio is another ratio widely used to value stocks. It was first used by Ken Fisher.
Keros Therapeutics's P/S Ratio for today is calculated as
P/S Ratio | = | Share Price | / | Revenue per Share (TTM) |
= | 66.700000 | / | 0.137 | |
= | 486.86 |
Keros Therapeutics's Share Price of today is $66.700000.
Keros Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2020 was 0.137 (Dec. 2019 ) + 0 (Mar. 2020 ) + 0 (Jun. 2020 ) + 0 (Sep. 2020 ) = $0.14.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
It can also be calculated from the numbers for the whole company:
P/E Ratio | = | Market Cap | / | Revenue |
The revenue here is for the trailing 12 months.
The P/S ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The P/S ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The P/S ratio is a great valuation tool for evaluating cyclical businesses where the P/E ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the P/S ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
Similar to the Price/Earnings ratio and Price/Cash Flow or Price/Free Cash Flow, the P/E ratio measures the valuation based on the earning power of the company. This is where it is different from Price/Book ratio, which measures the valuation based on the company's balance sheet.
The P/S ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
No Headline